Blood Testing in Olomouc

A full blood count with five-part white cell differential, analysed on the Mindray BC-6200 haematology platform at PKBH's Olomouc central laboratory. The CBC measures red cells, haemoglobin, haematocrit, MCV, MCH, MCHC, and platelet indices; the differential distinguishes neutrophils (including band forms), lymphocytes (and reactive variants), eosinophils, basophils, monocytes, and flags any abnormal or pathological cells for manual smear review. At 154 Kč all-in, this is one of the most accessible haematological screens available in the Czech Republic without a referral.

A fourth-generation HIV 1+2 antigen/antibody combination test, offered twice weekly (Monday and Thursday) at PKBH Olomouc with results available the same afternoon. The 440 Kč price covers everything — draw, separation, and the test. A certificate can be issued in Czech, English, or Russian, making this useful for visa applications, employment medicals, and personal health checks. No referral required; walk-in from 07:00.

A ten-substance urine drug screen covering amphetamine, barbiturates, benzodiazepines, cocaine, ecstasy (MDMA), methamphetamine, opiates, methadone, tricyclic antidepressants, and marijuana (THC). Performed by immunoassay at PKBH Olomouc on a single spot urine sample — no blood draw required. At 454 Kč with same-day results, this is among the most affordable validated drug panels in the Czech Republic. Walk-in, no referral.

A nine-biomarker metabolic snapshot assessing blood glucose regulation, insulin production, kidney function, and liver health in a single fasting draw. At PKBH Olomouc, HbA1c is quantified by high-performance liquid chromatography on the Tosoh G8 analyser — the gold-standard method used in clinical trials — giving a precise three-month average blood glucose that point-of-care glucometers cannot replicate. C-peptide (a proxy for endogenous insulin production) distinguishes insulin resistance from deficiency. Walk-in, no referral needed, results by end of day.

A two-tier Lyme disease serology screen covering Anti-Borrelia burgdorferi IgG and IgM antibodies by ELISA — the first line of the CDC/EUCALB two-tier testing algorithm for Lyme borreliosis. PKBH Olomouc offers this self-pay without a referral, with results same or next working day. If the ELISA is positive or equivocal, confirmatory IgG and IgM Western blot tests are available at the same laboratory, completing the two-tier protocol without changing provider.

A four-marker immune surveillance panel measuring all four major immunoglobulin classes — IgE (allergy driver), IgA (mucosal immunity), IgG (main memory antibody), and IgM (acute immune response). Together they reveal the balance and functionality of the humoral immune system. PKBH Olomouc uses the VirClia Lotus or i-Chroma II immunoassay platforms and the SEKK-accredited Mindray and Immulite systems. Useful for investigating recurrent infections, suspected immunodeficiency, chronic allergy, or autoimmune conditions. Walk-in, no referral.

A four-marker oncological surveillance panel for men, covering PSA (total and free ratio for prostate cancer risk stratification), AFP (hepatocellular carcinoma and germ cell tumour marker), and CEA (colorectal, lung, gastric). At PKBH, tumour markers run on the Abbott Alinity ii and DPC Immulite 2000XPi immunochemistry platforms under SEKK accreditation. Self-pay access without referral makes this a practical annual check for men over 50 or those with relevant family history.

A five-marker nutritional deficiency screen covering the vitamins and minerals most commonly deficient in Central European adults — Vitamin D, Vitamin B12, folate, ferritin, and magnesium. At PKBH Olomouc, Vitamin D and B12 are measured by immunochemistry on the DPC Immulite 2000XPi or Abbott Alinity ii, folate by chemiluminescence, and ferritin on the Mindray BS-800 M2 biochemistry line. Vitamin D was added to the PKBH test menu in May 2023 following patient demand. Walk-in access, no referral required.

A comprehensive nine-biomarker assessment of cardiovascular risk, covering the full lipid spectrum together with key inflammatory and vascular markers. At PKBH's Olomouc central laboratory, biochemistry assays run on the Mindray BS-800 M2 analyser, Apolipoprotein A1 and B are quantified by immunoturbidimetry, and Lipoprotein(a) is measured alongside Homocysteine — markers that standard NHS-style cholesterol checks omit entirely. The combined picture distinguishes true low-density atherogenic particles from HDL-protected cholesterol and flags elevated inflammatory tone driven by CRP. Walk-in access, no referral required, results by end of day or next morning.

A five-marker thyroid panel measuring the pituitary signal (TSH), both active thyroid hormones (Free T3 and Free T4), and the two most clinically significant thyroid antibodies (Anti-TPO and Anti-Tg). Together these markers distinguish between hypothyroidism, hyperthyroidism, and autoimmune thyroid disease (Hashimoto's or Graves'). At PKBH Olomouc, immunochemistry assays run on the Abbott Alinity ii and DPC Immulite 2000XPi platforms under SEKK external QC, and walk-in self-pay access means no GP referral is needed to initiate investigation.

The basic first-trimester combined screening at G-CENTRUM Olomouc combines a blood test and a nuchal translucency ultrasound to calculate each individual woman's risk of fetal chromosomal conditions including Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13). The blood draw (measuring PAPP-A and free β-hCG hormones) is taken at 9–10 weeks of pregnancy; the ultrasound measurement of nuchal translucency — the fluid-filled space at the back of the fetal neck — follows at 11–14 weeks. Both results are combined with maternal age and pregnancy data to produce a personalised risk figure.

A nine-marker hormonal panel covering the full female reproductive endocrine axis — pituitary gonadotropins, ovarian hormones, androgens, and adrenal contributors. At PKBH Olomouc, all hormones are measured by immunochemistry on the Abbott Alinity ii or DPC Immulite 2000XPi platforms, both SEKK-accredited. The panel is suitable for investigation of menstrual irregularity, fertility issues, PCOS, perimenopause, or excess androgen symptoms such as acne and hirsutism. No referral is needed for self-pay access.

The extended first-trimester combined screening at G-CENTRUM Olomouc builds on the basic chromosomal risk assessment by adding preeclampsia screening — a critical distinction for women at higher risk of developing this serious blood pressure complication later in pregnancy. In addition to the PAPP-A and free β-hCG blood markers and the nuchal translucency ultrasound, the extended version includes measurement of PlGF (placental growth factor) in the blood, uterine artery Doppler flow measurement by ultrasound, and blood pressure assessment. These additional data points allow calculation of a personalised preeclampsia risk score alongside the chromosomal risk figures.

A six-marker oncological surveillance panel for women, covering the key gynecological cancer markers (CA 125, CA 15-3, HE4), the gastrointestinal markers (CA 19-9, CEA), and AFP (liver and germ cell). HE4 combined with CA 125 in the ROMA algorithm significantly improves ovarian cancer risk classification compared with CA 125 alone. All markers run on Abbott Alinity ii or DPC Immulite 2000XPi at PKBH Olomouc under SEKK external quality control.

The ALEX Allergy Xplorer panel is one of the most comprehensive single-draw allergy blood tests available in Europe, testing sensitisation to more than 280 allergen components from a single venous sample. Unlike skin-prick tests or standard single-allergen IgE panels, ALEX2 uses multiplex luminescence immunoassay technology to measure specific IgE antibodies at the molecular component level — identifying exactly which protein within a pollen, mite, or food is triggering a response. At Laboratoře Mikrochem, this analysis is performed in their ISO 15189-accredited immunology laboratory in Olomouc, with results available within 7 working days. The panel covers all major inhalant allergens (grass, tree, and weed pollens; dust mites; moulds; animal epithelia), insect venoms, and a broad food allergen set including milk proteins (casein, whey), egg, wheat gluten, soy, tree nuts, peanuts, shellfish, and tropical fruits. A single venous blood draw is all that is needed — no repeated skin punctures, no allergen exposure on the day.

Non-invasive prenatal testing (NIPT) at G-CENTRUM Olomouc analyses cell-free fetal DNA circulating in the mother's blood to screen for chromosomal conditions with 99% accuracy — far exceeding the 85–90% detection rate of standard combined screening. The clinic uses the TRISOMY test platform via SPADIA laboratory. A single blood draw from week 11 of pregnancy is all that is required; results are returned without any risk to the fetus (unlike amniocentesis or CVS). Four tiers of the test are available depending on how many conditions need to be screened.

SPEA Olomouc operates a fully accredited ČIA ISO 15189 laboratory (accreditation No. 8146, held since 2011) and opens it to self-pay patients who do not hold a Czech health insurance card or whose specific tests are not covered by their insurer. The laboratory runs Roche Cobas 6000 for biochemistry and immunochemistry, Beckman Coulter DxH 500 and 900 analysers for haematology, and a Ceveron Alfa platform for coagulation — offering more than 80 analytes including the full lipid panel (with Lp(a) added in September 2025), thyroid function (TSH, fT3, fT4, anti-TPO, anti-TG), liver enzymes, kidney function, HbA1c, tumour markers (AFP, CEA, CA 125, CA 15-3, CA 19-9), and hormone panels (FSH, LH, prolactin, testosterone, estradiol, cortisol). Blood collection is accepted Monday to Friday from 6:30 to 12:00, with STATIM urgent processing available until 15:00.